In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 C52H97NO18 1023.670570 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 C54H101NO18 1051.701871 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 C56H105NO18 1079.733171 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 C58H109NO18 1107.764471 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 C60H111NO18 1133.780121 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 C60H113NO18 1135.795771 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 44:2;O2 C62H115NO18 1161.811421 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galβ1-4Glcβ-Cer 44:1;O2 C62H117NO18 1163.827071 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 34:1;O2 C58H107NO22 1169.728481 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 C58H107NO23 1185.723396 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 36:1;O2 C60H111NO22 1197.759781 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 C60H111NO23 1213.754696 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 38:1;O2 C62H115NO22 1225.791081 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 C60H110N2O23 1226.749944 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 34:1;O2 C60H110N2O23 1226.749944 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2 C60H110N2O23 1226.749944 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2 C60H110N2O23 1226.749944 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 C62H115NO23 1241.785996 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 40:1;O2 C64H119NO22 1253.822381 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 C62H114N2O23 1254.781245 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 36:1;O2 C62H114N2O23 1254.781245 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2 C62H114N2O23 1254.781245 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2 C62H114N2O23 1254.781245 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 C64H119NO23 1269.817296 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 42:2;O2 C66H121NO22 1279.838031 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 42:1;O2 C66H123NO22 1281.853681 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 C64H118N2O23 1282.812545 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 38:1;O2 C64H118N2O23 1282.812545 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2 C64H118N2O23 1282.812545 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2 C64H118N2O23 1282.812545 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 C66H121NO23 1295.832946 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 C66H123NO23 1297.848596 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 44:2;O2 C68H125NO22 1307.869331 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(Fucα1-2)Galβ1-4Glcβ-Cer 44:1;O2 C68H127NO22 1309.884981 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 C66H122N2O23 1310.843845 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 40:1;O2 C66H122N2O23 1310.843845 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2 C66H122N2O23 1310.843845 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2 C66H122N2O23 1310.843845 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 44:2;O2 C68H125NO23 1323.864246 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3Galα1-3Galβ1-4Glcβ-Cer 44:1;O2 C68H127NO23 1325.879896 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 C68H124N2O23 1336.859495 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:2;O2 C68H124N2O23 1336.859495 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2 C68H124N2O23 1336.859495 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2 C68H124N2O23 1336.859495 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 C68H126N2O23 1338.875145 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:1;O2 C68H126N2O23 1338.875145 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2 C68H126N2O23 1338.875145 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GlcNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2 C68H126N2O23 1338.875145 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:2;O2 C70H128N2O23 1364.890795 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]
Galα1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 44:2;O2 C70H128N2O23 1364.890795 Neutral glycosphingolipids [SP05] Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]